Dec, 16 2022

Der globale Markt für Antikoagulationstherapien wächst im Prognosezeitraum 2019–2026 deutlich

Laut dem neuen Marktbericht von Data Bridge Market Research belief sich der globale Markt für Antikoagulationstherapien im Jahr 2018 auf 25,59 Milliarden US-Dollar und wuchs im Prognosezeitraum von 2019 bis 2026 mit einer durchschnittlichen jährlichen Wachstumsrate (CAGR) von 8,01 %.

Globaler Markt für Antikoagulationstherapien

Globaler Markt für Antikoagulationstherapien

Die Antikoagulationstherapie umfasst Medikamente und Diagnosemethoden, die sich auf die Lösung von Blutgerinnseln konzentrieren. Blutgerinnsel entstehen, wenn sich Proteine im Blut zu einer festen Masse verbinden. Diese festen Massen, auch Blutgerinnsel genannt, verstopfen die Arterien und verursachen schließlich Herzinfarkte oder Schlaganfälle. Antikoagulationsmedikamente sollen die Gerinnselbildung beeinflussen und so Herzinfarkte und Schlaganfälle verhindern.

Den vollständigen Bericht finden Sie unter https://databridgemarketresearch.com/reports/global-anticoagulation-therapy-market

Segmentierung: Globaler Markt für Antikoagulationstherapie

Der globale Markt für Antikoagulationstherapien ist nach Arzneimittelklasse, Produkttyp, Verabreichungsweg, Anwendung, Vertriebskanal und Geografie segmentiert.

Nach Arzneimittelklasse (NOAK, Heparin, NMH, Warfarin, Sonstige), Produkttyp (Arzneimittel, Tests, Service), Verabreichungsweg (oral, injizierbar), Anwendung ( Herz-Kreislauf-Erkrankungen , Koronararterienerkrankungen, Herzrhythmusstörungen, Myokardinfarkt, TVT, Herzklappenersatz), Vertriebskanal (Krankenhäuser, Kliniken, Einzelhandel, Online), Geografie (Nordamerika, Südamerika, Europa, Asien-Pazifik, Naher Osten und Afrika)

WACHSTUMSFAKTOREN IM MARKT FÜR ANTIKOAGULATIONSTHERAPIEN:

Steigende Zahl von Herz-Kreislauf-Erkrankungen:

Laut der Weltgesundheitsorganisation sind Herz-Kreislauf-Erkrankungen weltweit die häufigste Todesursache und verursachen mehr Todesfälle als jede andere Ursache. Von den geschätzten 56,9 Millionen Todesfällen sind Herz-Kreislauf-Erkrankungen für rund 17,9 Millionen verantwortlich. Rund 85 % dieser Todesfälle durch Herz-Kreislauf-Erkrankungen waren auf Herzinfarkt und Schlaganfall zurückzuführen. Es wird erwartet, dass diese Zahl die Nachfrage nach Antikoagulationstherapien positiv beeinflusst, da sie das Problem der durch Schlaganfälle verursachten Blutgerinnsel lösen.

Globaler Markt für Antikoagulationstherapien

Wichtige Marktkonkurrenten: Globaler Markt für Antikoagulationstherapie

Zu den derzeit größten Wettbewerbern auf dem Markt für Antikoagulationstherapien zählen Abbott, Baxter, AstraZeneca, Bayer AG, Boehringer Ingelheim International GmbH, Eli Lilly and Company, Bristol-Myers Squibb Company, Merck & Co. Inc., Genentech Inc., GlaxoSmithKline plc., Pfizer Inc., Sanofi, Novartis AG, Aspen Holdings, DAIICHI SANKYO COMPANY LIMITED, Johnson & Johnson Services Inc., Portola Pharmaceuticals Inc., Siemens AG, CoaguSense Inc. und Mitsubishi Tanabe Pharma Corporation.

Verwandte Berichte durchsuchen :

Globaler Markt für Hämophiliebehandlungen, nach Produkt (plasmabasierte Gerinnungsfaktorkonzentrate, rekombinante Gerinnungsfaktorkonzentrate, Desmopressin, Antifibrinolytika), Typ (Hämophilie A, Hämophilie B, Hämophilie C, Sonstige), Therapie (On-Demand, Prophylaxe), Behandlung (Substitutionstherapie, ITI-Therapie, Gentherapie), Geografie (Nordamerika, Südamerika, Europa, Asien-Pazifik, Naher Osten und Afrika) – Branchentrends und Prognose bis 2026

https://databridgemarketresearch.com/reports/global-hemophilia-treatment-market

Globaler Markt für Psoriasis-Behandlungen: Der globale Markt für Psoriasis-Behandlungen ist segmentiert nach Anwendung (topische Therapeutika, systemische Therapeutika, Kombinationen), nach Endverbrauchern (Krankenhausapotheke, Kliniken, Einzelhandelsapotheken, Online-Verkauf), nach Geografie (Nordamerika, Südamerika, Europa, Asien-Pazifik, Naher Osten und Afrika) – Branchentrends und Prognose bis 2025

https://databridgemarketresearch.com/reports/global-psoriasis-treatment-market

Globaler Blutplasmamarkt, nach Typ (Hyperimmunglobulin, Albumin, Faktor VIII, Faktor IX, Immunglobulin, Sonstige), Anwendung (Hypogammaglobulinämie, Immunschwächekrankheiten, Hämophilie, Von-Willebrand-Syndrom (vWD), Sonstige Anwendungen), Endverbraucher (Krankenhäuser, Kliniken, Sonstige Endverbraucher), Geografie (Nordamerika, Südamerika, Europa, Asien-Pazifik, Naher Osten und Afrika) – Branchentrends und Prognose bis 2025

https://databridgemarketresearch.com/reports/global-blood-plasma-market

CHOOSE LICENCE TYPE

Enterprise User 7000
Single User 4800
DBMR Factbook 3000
DBMR Prime 8000
DBMR Nucleus 12000

Buy Now

Advance Formative Research Customization Request for bulk Reports

Latest News

Global Oral Insulin Market for Type 1 and Type 2 Diabetes:

Top Key Players in the Agriculture Variable Rate Technology Market: Enhancing Precision Farming for Higher Efficiency

Leading Players in the AI in Agriculture Market: Revolutionizing Farming with Smart Technologies

Leading Players in the Farm Management Software Market: Driving Digital Transformation in Agriculture

Leading Players in the Data Center Service Market: Enhancing Digital Infrastructure with Scalable and Secure Solutions

VIEW ALL

Client Testimonials

Claudio Rondena

Group Business Development & Strategic Marketing Director,
C.O.C Farmaceutici SRL

"This morning we were involved in the first part, the data presentation of MKT analysis, selected abstract from your work. The board team was really impressed and very appreciated, as well."

David Manning - Thermo Fisher Scientific

Director, Global Strategic Accounts,

Dear Ricky,
I want to thank you for the excellent market analysis (LIMS INSTALLED BASE DATA) that you and your team delivered, especially end of year on short notice. Sachin and Shraddha captured the requirements, determined their path forward and executed quickly.
You, Sachin and Shraddha have been a pleasure to work with – very responsive, professional and thorough. Your work is much appreciated.

Manager - Market Analytics,

Uriah D. Avila - Zeus Polymer Solutions

Thank you for all the assistance and the level of detail in the market report. We are very pleased with the results and the customization. We would like to continue to do business.

Business Development Manager,

(Pharmaceuticals Partner for Nasal Sprays) | Renaissance Lakewood LLC

DBMR was attentive and engaged while discussing the Global Nasal Spray Market. They understood what we were looking for and was able to provide some examples from the report as requested. DBMR Service team has been responsive as needed. Depending on what my colleagues were looking for, I will recommend your services and would be happy to stay connected in case we can utilize your research in the future.

Business Intelligence and Analytics,

Ipsen Biopharm Limited

We are impressed by the CENTRAL PRECOCIOUS PUBERTY (CPP) TREATMENT report - so a BIG thanks to you colleagues.

Competition Analyst,

Basler Web

I just wanted to share a quick note and let you know that you guys did a really good job. I’m glad I decided to work with you. I shall continue being associated with your company as long as we have market intelligence needs.

Marketing Director,

Buhler Group

It was indeed a good experience, would definitely recommend and come back for future prospects.

COO,

A global leader providing Drug Delivery Services

DBMR did an outstanding job on the Global Drug Delivery project, We were extremely impressed by the simple but comprehensive presentation of the study and the quality of work done. This report really helped us to access untapped opportunities across the globe.

Marketing Director,

Philips Healthcare

The study was customized to our targets and needs with well-defined milestones. We were impressed by the in-depth customization and inclusion of not only major but also minor players across the globe. The DBMR Market position grid helped us to analyze the market in different dimension which was very helpful for the team to get into the minute details.

Product manager,

Fujifilms

Thankful to the team for the amazing coordination, and helping me at the last moment with my presentation. It was indeed a comprehensive report that gave us revenue impacting solution enabling us to plan the right move.

Investor relations,

GE Healthcare

Thank you for the report, and addressing our needs in such short time. DBMR has outdone themselves in this project with such short timeframe.

Market Analyst,

Medincell

We found the results of this study compelling and will help our organization validate a market we are considering to enter. Thank you for a job well done.

Andrew - Senior Global Marketing Manager,

Medtronic (US)

I want to thank you for your help with this report – It’s been very helpful in our business planning and it well organized.

Amarildo - Manager, Global Strategic Alignment

MasterCard

We believe the work done by Data Bridge Team for our requirements in the North America Loyalty Management Market was fantastic and would love to continue working with your team moving forward.

Tor Hammer

Green Nexus LLc

Thank you for your quick response to this unfortunate circumstance. Please extend my thanks to your reach team. I will be contacting you in the future with further projects

Tommaso Finocchiaro

Market Intelligence Specialist Nippon Gasses

I acknowledge the difficulty given by the very short warning for this report, and I think that its quality and your delivering time have been very satisfying. Obviously, as a provider Data Bridge Market Research will be considered as a plus for future needs of Nippon Gases.

Yuki Kopyl (Asian Business Development Department)

UENO FOOD TECHNO INDUSTRY, LTD. (JAPAN)

Xylose report was very useful for our team. Thank you very much & hope to work with you again in the future

Der globale Markt für Antikoagulationstherapien wächst im Prognosezeitraum 2019–2026 deutlich

Segmentierung: Globaler Markt für Antikoagulationstherapie